164 related articles for article (PubMed ID: 1476621)
1. Genetically engineered antibodies: progress and prospects.
Wright A; Shin SU; Morrison SL
Crit Rev Immunol; 1992; 12(3-4):125-68. PubMed ID: 1476621
[TBL] [Abstract][Full Text] [Related]
2. Genetically engineered antibodies and their application to brain delivery.
Morrison SL; Shin SU
Adv Drug Deliv Rev; 1995 Jul; 15(1-3):147-175. PubMed ID: 35524387
[TBL] [Abstract][Full Text] [Related]
3. Protein engineering of antibodies.
Sandhu JS
Crit Rev Biotechnol; 1992; 12(5-6):437-62. PubMed ID: 1423650
[TBL] [Abstract][Full Text] [Related]
4. Recent progress in biomolecular engineering.
Ryu DD; Nam DH
Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
[TBL] [Abstract][Full Text] [Related]
5. Effects of genetic engineering on the pharmacokinetics of antibodies.
Colcher D; Goel A; Pavlinkova G; Beresford G; Booth B; Batra SK
Q J Nucl Med; 1999 Jun; 43(2):132-9. PubMed ID: 10429508
[TBL] [Abstract][Full Text] [Related]
6. Antibody engineering: an overview.
O'Kennedy R; Roben P
Essays Biochem; 1991; 26():59-75. PubMed ID: 1778186
[TBL] [Abstract][Full Text] [Related]
7. [Production of antibodies with the aid of genetic technology].
Hammarström L; Smith E
Nord Med; 1990; 105(1):13-5, 23. PubMed ID: 2300434
[TBL] [Abstract][Full Text] [Related]
8. Man-made antibodies.
Winter G; Milstein C
Nature; 1991 Jan; 349(6307):293-9. PubMed ID: 1987490
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and biodistribution of genetically-engineered antibodies.
Colcher D; Pavlinkova G; Beresford G; Booth BJ; Choudhury A; Batra SK
Q J Nucl Med; 1998 Dec; 42(4):225-41. PubMed ID: 9973838
[TBL] [Abstract][Full Text] [Related]
10. In vitro antibodies: strategies for production and application.
Morrison SL
Annu Rev Immunol; 1992; 10():239-65. PubMed ID: 1590987
[TBL] [Abstract][Full Text] [Related]
11. Humanization of a murine monoclonal antibody by simultaneous optimization of framework and CDR residues.
Wu H; Nie Y; Huse WD; Watkins JD
J Mol Biol; 1999 Nov; 294(1):151-62. PubMed ID: 10556035
[TBL] [Abstract][Full Text] [Related]
12. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
[TBL] [Abstract][Full Text] [Related]
13. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112
[TBL] [Abstract][Full Text] [Related]
14. Construction and characterization of chimeric and humanized forms of a broadly neutralizing monoclonal antibody to HIV-1.
Major JG; Liou RS; Sun LK; Yu LM; Starnes SM; Fung MS; Chang TW; Chang NT
Hum Antibodies Hybridomas; 1994; 5(1-2):9-17. PubMed ID: 7858187
[TBL] [Abstract][Full Text] [Related]
15. Designer genes: recombinant antibody fragments for biological imaging.
Wu AM; Yazaki PJ
Q J Nucl Med; 2000 Sep; 44(3):268-83. PubMed ID: 11105590
[TBL] [Abstract][Full Text] [Related]
16. Expression vectors for chicken-human chimeric antibodies.
Nishibori N; Shimamoto T; Nakamura N; Shimokawa M; Horiuchi H; Furusawa S; Matsuda H
Biologicals; 2004 Dec; 32(4):213-8. PubMed ID: 15572103
[TBL] [Abstract][Full Text] [Related]
17. A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen.
Sahagan BG; Dorai H; Saltzgaber-Muller J; Toneguzzo F; Guindon CA; Lilly SP; McDonald KW; Morrissey DV; Stone BA; Davis GL
J Immunol; 1986 Aug; 137(3):1066-74. PubMed ID: 3088107
[TBL] [Abstract][Full Text] [Related]
18. Engineered antibodies take center stage.
Huston JS; George AJ
Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
[TBL] [Abstract][Full Text] [Related]
19. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
[TBL] [Abstract][Full Text] [Related]
20. SDR grafting of a murine antibody using multiple human germline templates to minimize its immunogenicity.
Gonzales NR; Padlan EA; De Pascalis R; Schuck P; Schlom J; Kashmiri SV
Mol Immunol; 2004 Jul; 41(9):863-72. PubMed ID: 15261458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]